Global Biosimilars Market - Market Size, Share & Industry Trends, Growth Analysis Report By Product Type, By Consumption and Forecast 2019 - 2025


DescriptionTable of ContentList of TablesList of Figures
Introduction Biosimilars Market was valued at USD X.X Billion in 2018 and is projected to reach USD X.X billion by 2025, at a CAGR of X.X % from 2019-2025. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. Regulations for biosimilars play a vital role in maintaining the viability and balance between original and biosimilars products. The market is driven by factors such rising prevalence of chronic diseases such as cancer and diabetes supplement the growing demands of pharmaceutical drugs, especially for the high priced patented drugs. Geographical Overview At a global level, North America region was holding the highest market share in 2018. Whereas, Asia Pacific region is considered as the fastest growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of Biosimilars Market with its high population base. Countries from the European Union presently dominate the market owing to the favorable government regulations in this region. North America biosimilars market is currently witnessing restrictions due to the flexible and ineffective regulations. Segmental Overview Biosimilars Market is segmented as per below specifications - By Product Type: • Human growth hormone • Erythropoietin • Monoclonal antibodies • Insulin • Interferon By Consumption: • Blood disorders • Oncology diseases • Chronic and autoimmune diseases • Growth hormone deficiencies By Distribution Channel: • Type A • Type B Competitor Analysis Biosimilars Market has presence of some of the key major players across globe which includes • Synthon Pharmaceuticals, Inc. • Teva Pharmaceutical Industries Ltd. • LG Life Sciences • Celltrion • Biocon • Hospira • Merck Serono (Merck Group) • Biogen idec, Inc. • Genentech (Roche Group). These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies. By Geographical Locations: • North America o U.S. o Canada • Europe o U.K. o France o Italy o Germany o Spain o Russia & CIS o Rest of Europe • Asia-Pacific o China o India o Japan o South Korea o ASEAN o Rest of Asia Pacific • Latin America o Brazil o Argentina o Rest of LATAM • Middle East & Africa o UAE o South Africa o Rest of MEA Highlights of the report What is Biosimilars Market? Who all are key market players in the industry? How the Parent Industry is growing? Where are the key opportunities for new market entrant? A comprehensive analysis, which covers key growth factors across the value chain Recent developments in market Granular Market Segmentation Market size projection based on Historical & current market trends Market share analysis and key strategies adopted by leading Players Production Cost & Sensitivity Analysis Country Level Market Analysis of Top 16 countries Data Driven Decision Recommendations